Influvac Tetra Indications/Uses

Prophylaxis of influenza; especially those who run an increased risk of associated complications.
INFLUVAC Tetra is indicated in adults and children from 3 years of age.
The use of INFLUVAC Tetra should be based on official recommendations.
Vaccination is particularly recommended for the following categories of patients, depending on national immunization policies: Persons aged ≥ 65 years, regardless their health condition.
Adults and children from 3 years of age with chronic disorders of the pulmonary or cardiovascular systems, including asthma.
Adults and children from 3 years of age with chronic metabolic diseases such as diabetes mellitus.
Adults and children from 3 years of age with chronic renal dysfunction.
Adults and children from 3 years of age with immunodeficiencies due to disease or immunosuppressant medication (e.g., cytostatics or corticosteroids) or radiotherapy.
Children from 3 years of age who receive long-term acetylsalicylic acid containing medication and might therefore be at risk for developing Reye's syndrome following an influenza infection.